ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

September 13, 2002

MIT Researcher Ingested P-32; NRC Investigating

October 27, 1995

In Brief: Appropriations Hearings Scheduled; Zubro Heads AACI, Nelson Elected ACCC President

February 10, 1978

In Brief: NCI Holds Paylines To 160, 165 for Now While Anticipating Another OMB Rescission Request

November 14, 1986

ODAC Recommends FDA Approval For Grain Tumor Implant

June 21, 1996

NCI-Approved Clinical Trials

October 27, 2006